| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.49B | 18.35B | 18.02B | 16.33B | 16.10B | 14.79B |
| Gross Profit | 4.18B | 3.95B | 3.92B | 3.57B | 3.45B | 2.84B |
| EBITDA | 1.63B | 1.45B | 1.58B | 1.51B | 1.49B | 1.23B |
| Net Income | 1.30B | 1.26B | 1.07B | 989.67M | 944.70M | 844.00M |
Balance Sheet | ||||||
| Total Assets | 14.37B | 14.37B | 13.49B | 12.55B | 10.25B | 9.61B |
| Cash, Cash Equivalents and Short-Term Investments | 6.30B | 6.23B | 6.84B | 6.85B | 5.06B | 4.47B |
| Total Debt | 230.00M | 230.00M | 230.00M | 240.28M | 241.12M | 283.32M |
| Total Liabilities | 3.52B | 3.49B | 3.35B | 2.93B | 3.03B | 3.10B |
| Stockholders Equity | 10.85B | 10.87B | 10.13B | 9.62B | 7.17B | 6.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 216.00M | 974.95M | 879.39M | 971.81M | 1.00B |
| Operating Cash Flow | 0.00 | 255.00M | 1.04B | 891.96M | 1.02B | 1.04B |
| Investing Cash Flow | 0.00 | -68.00M | -259.85M | -304.71M | -134.34M | 58.50M |
| Financing Cash Flow | 0.00 | -780.00M | -672.01M | 1.10B | -324.11M | -215.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥16.44B | 88.89 | ― | 3.98% | -5.92% | 3.16% | |
69 Neutral | ¥15.41B | 8.09 | ― | 3.60% | 2.46% | -5.85% | |
67 Neutral | ¥11.19B | 9.17 | ― | 1.19% | 13.46% | 91.02% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥17.81B | -16.73 | ― | ― | 9.82% | -32.60% | |
59 Neutral | ¥13.17B | 46.76 | ― | ― | 6.24% | ― | |
57 Neutral | ¥14.32B | 15.26 | ― | 1.75% | 13.47% | 296.94% |